Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDunedin Ent.it. Regulatory News (DNE)

  • This share is currently suspended. It was suspended at a price of 470.00

Share Price Information for Dunedin Ent.it. (DNE)

Share Price is delayed by 15 minutes
Get Live Data
470.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: -
DNE Live PriceLast checked at - London Stock Exchange

Intraday Dunedin Ent.it. Share Chart

3rd Quarter Results

12 Nov 2020 07:00

RNS Number : 0111F
Dunedin Enterprise Inv Trust PLC
12 November 2020
 

Dunedin Enterprise Investment Trust PLC

 

LEI: 213800E2VLUZ5AF9Z434

 

Date: 12 November 2020

Time: 07.00am

 

Quarterly Update

 

1. Unaudited net asset value per share

 

The unaudited net asset value per share at 30 September 2020 was 393.1p. This represents a total return per share of 3.5% during the quarter when compared to the net asset value per share of 379.8p as at 30 June 2020.

 

2. Share price

 

The share price has increased from 263p to 299p in the quarter to 30 September 2020. The share price total return for the quarter to 30 September 2020 was 13.7%. This compares to a decrease in the FTSE Small Cap Index of 2.2% over the same period. The discount to net asset value at 30 September 2020 was 23.9%. 

 

3. Balance Sheet

 

The unaudited balance sheet as at 30 September 2020 is noted below: -

 

 

£'m

Investments: -

 

Dunedin managed

54.1

Third party managed

4.6

 

58.7

 

 

Cash and near cash

24.0

Other assets and liabilities

(1.6)

 

 

Total net assets

81.1

 

 

Net asset value per share (p)

393.1p

 

4. Net asset value movements

 

The portfolio of investments has been re-valued at 30 September 2020. The increase in net asset value in the quarter can be attributed to valuation increases at GPS (£2.0m), U-POL (£1.8m) and Incremental (£1.1m) offset by a valuation reduction at FRA (£1.9m).

 

5. Cash and Commitments

 

Dunedin Enterprise had cash and near cash balances of £24.0m at 30 September 2020. Following the quarter end a distribution of £10m will be made on 12 November 2020 to shareholders via a tender offer. Following this distribution total cash and near cash balances will be £14.0m.

 

Outstanding capital commitments to limited partnership funds are £20.1m. It is expected that £9m of the total outstanding commitments will ultimately be drawn over the remaining life of the funds.

 

 

6. Tender Offer

 

A Tender Offer returning £10m to shareholders was approved at a General Meeting held on 4 November 2020. The Tender Offer price is 384.84p per share, a 2.1% discount to the net asset value per share at 30 September 2020. The basic shareholder entitlement is 12.3225 per cent. Proceeds from the Tender Offer will be distributed to shareholders on 12 November 2020.

 

7. Outlook

 

The disruption and ongoing uncertainty created by the pandemic continues to be the main focus for portfolio companies. While each portfolio company has implemented plans, where possible, to address this threat, the generally strong financial position of portfolio companies has provided some protection.

 

Whilst there is continued uncertainty regarding the UK's ongoing relationship with the EU, the Board does not expect there to be any significant impact from Brexit on the operations of the Company. Each portfolio company has developed contingency plans to mitigate a variety of Brexit scenarios.

 

 

For further information, please contact:

 

Dunedin LLP

Company Secretary

Telephone: 0131 225 669

 

END

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRTGZMMMFMFGGZM
Date   Source Headline
29th Jan 20251:17 pmRNSStatement re First Distribution in Liquidation
6th Jan 20252:48 pmRNSResult of General Meeting
30th Dec 20245:30 pmRNSDunedin Enterprise Investment Trust
19th Dec 20243:38 pmRNSGM - Announcement of Suspension Timetable
19th Dec 20243:27 pmRNSGM - Announcement of Suspension Timetable
9th Dec 20247:00 amRNSHolding(s) in Company
4th Dec 202410:00 amRNSGeneral Meeting re: Member's Voluntary Liquidation
4th Dec 202410:00 amRNSPublication of Circular and Winding-up Timetable
3rd Dec 20248:44 amRNSGeneral Meeting re: Member's Voluntary Liquidation
29th Nov 20241:38 pmRNSPortfolio Update
1st Nov 20247:00 amRNSPreliminary Unaudited Net Asset Value at 30/09/24
11th Sep 20247:00 amRNSHalf-year Report
27th Aug 20247:00 amRNSDividend Declaration
5th Aug 20247:00 amRNSPortfolio Update
1st Aug 20247:00 amRNSPreliminary unaudited net asset value at 30/6/24
15th May 20241:17 pmRNS1st Quarter Results
15th May 20241:12 pmRNSResult of AGM
7th May 20245:37 pmRNSHolding(s) in Company
1st May 20247:00 amRNSPreliminary Unaudited Net Asset Value at 31/3/24
22nd Mar 20247:00 amRNSAnnual Financial Report
5th Feb 20241:58 pmRNSHolding(s) in Company
5th Feb 20241:56 pmRNSHolding(s) in Company
5th Feb 20241:54 pmRNSHolding(s) in Company
1st Feb 20247:00 amRNSPreliminary Unaudited Net Asset Value at 31/12/23
19th Dec 20232:34 pmRNSHolding(s) in Company
19th Dec 20232:22 pmRNSHolding(s) in Company
13th Dec 20237:00 amRNSDividend Declaration
21st Nov 20237:00 amRNSPremier Hytemp realisation & potential winding-up
16th Nov 20237:00 amRNS3rd Quarter Results
6th Nov 20234:33 pmRNSHolding(s) in Company
3rd Nov 20237:05 amRNSPortfolio Update
1st Nov 20237:00 amRNSPreliminary Unaudited Net Asset Value at 30/9/23
28th Sep 20237:00 amRNSPortfolio Update
15th Sep 20237:00 amRNSHalf-year Report
1st Aug 20237:00 amRNSPreliminary unaudited net asset value at 30/6/23
6th Jun 20239:01 amRNSHolding(s) in Company
22nd May 202310:05 amRNSHolding(s) in Company
10th May 20232:42 pmRNSResult of AGM
10th May 20232:42 pmRNS1st Quarter Results
2nd May 20237:00 amRNSPreliminary unaudited net asset value at 31/3/23
24th Mar 20237:00 amRNSAnnual Financial Report
1st Feb 20237:00 amRNSPreliminary Unaudited Net Asset Value at 31/12/22
7th Dec 20221:02 pmRNSDirector/PDMR Shareholding
7th Dec 20221:00 pmRNSDirector/PDMR Shareholding
7th Dec 20221:00 pmRNSDirector/PDMR Shareholding
6th Dec 202211:12 amRNSDirector/PDMR Shareholding
6th Dec 202211:09 amRNSDirector/PDMR Shareholding
1st Dec 202212:42 pmRNSHolding(s) in Company
30th Nov 20225:50 pmRNSDirector/PDMR Shareholding
30th Nov 20225:48 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.